SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-22-027275
Filing Date
2022-11-14
Accepted
2022-11-14 16:15:13
Documents
103
Period of Report
2022-09-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q nby20220930_10q.htm   iXBRL 10-Q 1932245
2 EXHIBIT 31.1 ex_438721.htm EX-31.1 8029
3 EXHIBIT 31.2 ex_438720.htm EX-31.2 8354
4 EXHIBIT 32.1 ex_438719.htm EX-32.1 4050
5 EXHIBIT 32.2 ex_438718.htm EX-32.2 3856
  Complete submission text file 0001437749-22-027275.txt   10835644

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA nby-20220930.xsd EX-101.SCH 104102
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE nby-20220930_cal.xml EX-101.CAL 62170
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE nby-20220930_def.xml EX-101.DEF 620258
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE nby-20220930_lab.xml EX-101.LAB 525823
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE nby-20220930_pre.xml EX-101.PRE 666236
97 EXTRACTED XBRL INSTANCE DOCUMENT nby20220930_10q_htm.xml XML 2248034
Mailing Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608
Business Address 2000 POWELL STREET, SUITE 1150 EMERYVILLE CA 94608 (510) 899-8800
NovaBay Pharmaceuticals, Inc. (Filer) CIK: 0001389545 (see all company filings)

IRS No.: 680454536 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33678 | Film No.: 221385539
SIC: 2834 Pharmaceutical Preparations